Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
70,611
-
Share change
-
+70,611
-
Total reported value
-
$258,083
-
Price per share
-
$3.65
-
Number of holders
-
10
-
Value change
-
+$258,083
-
Number of buys
-
10
Institutional Holders of Protagenic Therapeutics, Inc.new - COM (PTIX) as of Q2 2025
As of 30 Jun 2025,
Protagenic Therapeutics, Inc.new - COM (PTIX) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
70,611 shares.
The largest 10 holders included
Virtu Financial LLC, Alpine Global Management, LLC, MORGAN STANLEY, SUSQUEHANNA INTERNATIONAL GROUP, LLP, UBS Group AG, Tower Research Capital LLC (TRC), CITIGROUP INC, BANK OF AMERICA CORP /DE/, RAYMOND JAMES FINANCIAL INC, and HARBOR INVESTMENT ADVISORY, LLC.
This page lists
10
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.